TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Recommendation of “Buy” by Brokerages
Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) have earned an average recommendation of “Buy” from the nine brokerages that are covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12-month […]
Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI – Get Free Report) have earned an average recommendation of “Buy” from the nine brokerages that are covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12-month […]
